Mesa Laboratories, Inc. announced that it will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on May 31, 2024. Mesa?s Form 10-K will be filed the same day. The earnings announcement has been delayed as the company finalize the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to Clinical Genomics and Biopharmaceutical Development divisions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.6 USD | -1.51% |
|
-12.60% | -12.57% |
05/06 | Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 Revenue $58.9M, vs. Street Est of $55.3M | MT |
05/06 | Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 EPS $2.77, vs. Street Est of $1.75 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.57% | 49Cr | |
-5.81% | 18TCr | |
-1.63% | 11TCr | |
-4.14% | 6.75TCr | |
-6.56% | 4.61TCr | |
+13.22% | 4.58TCr | |
+6.13% | 4.16TCr | |
+19.93% | 3.11TCr | |
+13.61% | 2.48TCr | |
-5.36% | 2.43TCr |
- Stock Market
- Equities
- MLAB Stock
- News Mesa Laboratories, Inc.
- Mesa Laboratories, Inc. Delays Earnings Announcement for the Fourth Quarter and Full Fiscal Year 2024 Results